TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 139 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,925,000 | -15.7% | 1,221,979 | -19.9% | 0.00% | 0.0% |
| Q3 2016 | $5,845,000 | -5.1% | 1,526,146 | +6.5% | 0.00% | 0.0% |
| Q2 2016 | $6,161,000 | -0.4% | 1,432,702 | +7.2% | 0.00% | 0.0% |
| Q1 2016 | $6,188,000 | -68.4% | 1,336,411 | -31.5% | 0.00% | -80.0% |
| Q4 2015 | $19,556,000 | +25.6% | 1,949,742 | -6.6% | 0.01% | +25.0% |
| Q3 2015 | $15,571,000 | -75.3% | 2,087,330 | +57.2% | 0.00% | -73.3% |
| Q2 2015 | $62,972,000 | +38.9% | 1,327,405 | +7.3% | 0.02% | +36.4% |
| Q1 2015 | $45,347,000 | +5.2% | 1,237,628 | +14.0% | 0.01% | 0.0% |
| Q4 2014 | $43,115,000 | +315.8% | 1,085,742 | +108.9% | 0.01% | +266.7% |
| Q3 2014 | $10,369,000 | +44.2% | 519,734 | -2.5% | 0.00% | +50.0% |
| Q2 2014 | $7,189,000 | +64.2% | 532,945 | +32.5% | 0.00% | +100.0% |
| Q1 2014 | $4,379,000 | -14.2% | 402,148 | +6.5% | 0.00% | -50.0% |
| Q4 2013 | $5,104,000 | +36.0% | 377,484 | +14.4% | 0.00% | +100.0% |
| Q3 2013 | $3,754,000 | +83.1% | 329,886 | +13.1% | 0.00% | 0.0% |
| Q2 2013 | $2,050,000 | – | 291,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |